Rockefeller Capital Management L.P. Fibrogen Inc Transaction History

Rockefeller Capital Management L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.94 - $12.96 $293 - $479	-37 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$18.57 - $35.68 $185 - $356	-10 Reduced 21.28%	37 $0
Q1 2021 May 11, 2021	SELL	$31.0 - $55.72 $1,271 - $2,284	-41 Reduced 46.59%	47 $1,000
Q1 2020 May 12, 2020	BUY	$23.3 - $45.96 $2,050 - $4,044	88 New	88 $3,000
Q2 2019 Aug 09, 2019	SELL	$35.13 - $55.53 $1,159 - $1,832	-33 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$42.83 - $59.91 $1,413 - $1,977	33 New	33 $2,000
Q3 2018 Nov 02, 2018	SELL	$56.3 - $67.25 $112,712 - $134,634	-2,002 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$45.35 - $61.65 $90,790 - $123,423	2,002 New	2,002 $92,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $46.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.